Skip navigation.

HOME > Honorary Members > Membership > Fourth Subsection > Personal Information

Personal Information

Name Ōmura Satoshi Ōmura, Satoshi
Section Section II, Fourth Subsection
Date of Election 2001/12/12
Speciality Natural Products Organic Chemistry
Selected Bibliography
    1. R.W. Burg, B.M. Miller, E.E. Baker, J. Birnbaum, S.A. Currie, R. Hartman, Y.-L. Kong, R. Monaghan, G. Olson, I. Putter, J.B. Tunac, H. Wallick, E.O. Stapley, R. Oiwa and S. Ōmura. Avermectins, new family of potent anthelmintic agents: producing organism and fermentation. Antimicrob. Agents & Chemother., 15, 361-367 (1979).
    2. D.A. Hopwood, F. Malphatida, H.M. Kieser, H. Ikeda, J. Juncan, I. Fujii, B.A.M. Rudd, H.G. Floss, and S. Ōmura. Production of 'hybrid' antibiotics by genetic engineering. Nature, 314 (6012), 642-644 (1985).
    3. M. Hayashi, M.-C. Rho, A. Enomoto, A. Fukami, Y.-P. Kim, Y. Kikuchi, T. Sunazuka, T. Hirose, K. Komiyama, and S. Ōmura. Suppression of bone resorption by madindoline A, a novel nonpeptide antagonist to gp130. Proc. Natl. Acad. Sci., USA, 99, 14728-14739 (2002).
    4. H. Miyadera, K. Shiomi, H. Ui, Y. Yamaguchi, R. Masuma, H. Tomoda, H. Miyoshi, A. Osanai, K. Kita, and S. Ōmura. Atpenins, potent and specific inhibitors of mitochondria complex II (succinate-ubiquinone oxidoreductase). Proc. Natl. Acad. Sci., USA, 100, 473-477 (2003).
    5. H. Ikeda, J. Ishikawa, A. Hanamoto, M. Shinose, H. Kikuchi, T. Shiba, Y. Sasaki, M. Hattori, and S. Ōmura. Complete genome sequence and comparative analysis of the industrial microorganisms Streptomyces avermitilis. Nature Biotechnol., 21, 526-531 (2003).
    6. S. Ōmura and A. Crump. The life and times of ivermectin? a success story. Nature Reviews Microbiology, 2, 984-989 (2004).
    7. I. Namatame, H. Tomoda, S. Ishibashi, and S. Ōmura. Antiatherogenic activity of fungal beuveriolides, inhibitor of lipid droplet accumulation in macrophages. Proc. Natl. Acad. Sci., USA, 101, 7373-742 (2004).
    8. T. Sunazuka and S. Ōmura. Total synthesis of α-pyrone meroterpenoids, novel bioactive microbial metabolites. Chem. Rev., 105, 4559-4580 (2005).
    9. H. Gouda, T. Sunazuka, H. Ui, M. Handa, Y. Sakoh, Y. Iwai, S. Hirono, and S. Ōmura. Stereostructure of luminamicin, an anaerobic antibiotic, via molecular dynamics, NMR spectroscopy, and modified Mosher method. Proc. Natl. Acad. Sci., USA, 102, 18286-18291 (2005).
    10. M. Iwatsuki, H. Tomoda, R. Uchida, H. Gouda, S. Hirono, and S. Ōmura. Lariatins, antimycobacterial peptides produced by Rhodococcus sp. K01-B0171, have a Lasso structure. J. Am. Chem. Soc., 128, 7486-7491 (2006).
    11. Macrolide Antibiotics-Chemistry, Biology, and Practice, 2nd Ed., (Ed. by S. Ōmura), Academic Press, 2002.

↑Go to TOP